Mindy Simpson to Prospective Studies
This is a "connection" page, showing publications Mindy Simpson has written about Prospective Studies.
Connection Strength
0.043
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843.
Score: 0.025
-
Use of global assays to understand clinical phenotype in congenital factor VII deficiency. Haemophilia. 2013 Sep; 19(5):765-72.
Score: 0.019